side effects of semaglutide and tirzepatide vs. Semaglutide: What's the Difference? Health Tip of the Week,

doi:10.1289/ehp.6941

These medications were compared to dipeptidyl peptidase-4 inhibitors (DPP-4i), another common class of diabetes drugs

Speed of Loss Matters More Than Total Weight One of the most important clinical insights for patients on GLP-1 protocols is that the trigger for facial volume loss is not primarily how much weight is lost, it is how fast it comes off

Clinical data suggests semaglutide users report nausea in approximately 25-30% of cases, whereas tirzepatide shows nausea in 30-40% of users, likely due to dual-pathway activation creating stronger initial gastrointestinal effects

If youve been more active, you may be building muscle while losing fat, which can cause the number on the scale to stall even as your body composition improves

An experimental drug from Lilly, eloralintide, led to an average 11.3% weight loss over 12 weeks in a Phase 1 study, according to new results published last week at the diabetes conference